| Date Filed | Type | Description |
| 05/30/2023 |
4
| Versi Ebrahim (CEO) has filed a Form 4 on Adamis Pharmaceuticals Corp|
Txns:
| Granted 8,745 shares
@ $0
Granted 177,194 shares
@ $0
Granted 20,577 options to buy
@ $2.9, valued at
$59.7k
Granted 1,941 convertible preferred
@ $0 |
|
| 05/30/2023 |
4
| Desai Meera J. (Director) has filed a Form 4 on Adamis Pharmaceuticals Corp|
Txns:
| Granted 3,138 shares
@ $0 |
|
| 05/30/2023 |
4
| Versi Jannine (Director) has filed a Form 4 on Adamis Pharmaceuticals Corp|
Txns:
| Granted 177,194 shares
@ $0
Granted 5,144 options to buy
@ $2.9, valued at
$14.9k
Granted 1,941 convertible preferred
@ $0 |
|
| 05/30/2023 |
3
| Versi Jannine (Director) has filed a Form 3 on Adamis Pharmaceuticals Corp |
| 05/30/2023 |
3
| Versi Ebrahim (CEO) has filed a Form 3 on Adamis Pharmaceuticals Corp |
| 11/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| CARLO DENNIS J PHD (Former President & CEO) has filed a Form 4 on Adamis Pharmaceuticals Corp|
Txns:
| Exercised 250,000 restricted stock units
@ $0 |
|
| 05/26/2022 |
3
| REED VICKIE S (Director) has filed a Form 3 on Adamis Pharmaceuticals Corp |
| 05/26/2022 |
4
| REED VICKIE S (Director) has filed a Form 4 on Adamis Pharmaceuticals Corp|
Txns:
| Granted 50,000 options to buy
@ $0.41, valued at
$20.5k
|
|
| 03/22/2022 |
4
| Moss Ronald B. (Chief Medical Officer) has filed a Form 4 on Adamis Pharmaceuticals Corp|
Txns:
| Sold 8,199 shares
@ $0.6036, valued at
$4.9k
|
|
| 03/22/2022 |
4
| Marguglio David J. (SVP and Chief Business Officer) has filed a Form 4 on Adamis Pharmaceuticals Corp|
Txns:
| Sold 11,859 shares
@ $0.6001, valued at
$7.1k
|
|
| 03/22/2022 |
4
| CARLO DENNIS J PHD (President & CEO) has filed a Form 4 on Adamis Pharmaceuticals Corp|
Txns:
| Sold 10,490 shares
@ $0.5993, valued at
$6.3k
|
|
| 03/22/2022 |
4
| Benedicto David C. (CFO) has filed a Form 4 on Adamis Pharmaceuticals Corp|
Txns:
| Sold 3,603 shares
@ $0.6128, valued at
$2.2k
|
|
| 12/03/2021 |
4
| Benedicto David C. (CFO) has filed a Form 4 on Adamis Pharmaceuticals Corp|
Txns:
| Sold 13,554 shares
@ $0.785, valued at
$10.6k
|
|
| 12/03/2021 |
4
| Moss Ronald B. (Chief Medical Officer) has filed a Form 4 on Adamis Pharmaceuticals Corp|
Txns:
| Sold 35,553 shares
@ $0.785, valued at
$27.9k
|
|
| 12/03/2021 |
4
| Marguglio David J. (SVP and Chief Business Officer) has filed a Form 4 on Adamis Pharmaceuticals Corp|
Txns:
| Sold 50,757 shares
@ $0.785, valued at
$39.8k
|
|
| 12/03/2021 |
4
| CARLO DENNIS J PHD (President & CEO) has filed a Form 4 on Adamis Pharmaceuticals Corp|
Txns:
| Sold 47,870 shares
@ $0.785, valued at
$37.6k
|
|
| 10/06/2021 |
4
| Desai Meera J. (Director) has filed a Form 4 on Adamis Pharmaceuticals Corp|
Txns:
| Granted 50,000 rights
@ $0 |
|
| 10/06/2021 |
3
| Desai Meera J. (Director) has filed a Form 3 on Adamis Pharmaceuticals Corp |
| 06/02/2021 |
3
| Benedicto David C. (Principal Accounting Officer) has filed a Form 3 on Adamis Pharmaceuticals Corp |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Moss Ronald B. (Chief Medical Officer) has filed a Form 4 on Adamis Pharmaceuticals Corp|
Txns:
| Exercised 13,911 restricted stock units
@ $0 |
|
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/24/2020 |
4
| Hopkins Robert O (CFO) has filed a Form 4 on Adamis Pharmaceuticals Corp|
Txns:
| Sold 35,000 shares
@ $0.4052, valued at
$14.2k
|
|
| 11/20/2020 |
4
| Moss Ronald B. (Chief Medical Officer) has filed a Form 4 on Adamis Pharmaceuticals Corp|
Txns:
| Sold 8,532 shares
@ $0.4061, valued at
$3.5k
|
|
| 11/20/2020 |
4
| Hopkins Robert O (CFO) has filed a Form 4 on Adamis Pharmaceuticals Corp|
Txns:
| Sold 7,229 shares
@ $0.4061, valued at
$2.9k
|
|
| 11/20/2020 |
4
| CARLO DENNIS J PHD (President & CEO) has filed a Form 4 on Adamis Pharmaceuticals Corp|
Txns:
| Sold 10,665 shares
@ $0.4061, valued at
$4.3k
|
|
| 11/20/2020 |
4
| Daniels Karen K. (VP of Operations) has filed a Form 4 on Adamis Pharmaceuticals Corp|
Txns:
| Sold 5,333 shares
@ $0.4061, valued at
$2.2k
|
|
| 11/20/2020 |
4
| Marguglio David J. (SVP and Chief Business Officer) has filed a Form 4 on Adamis Pharmaceuticals Corp|
Txns:
| Sold 8,532 shares
@ $0.4061, valued at
$3.5k
|
|
| 10/01/2020 |
4
| Hopkins Robert O (CFO) has filed a Form 4 on Adamis Pharmaceuticals Corp|
Txns:
| Sold 20,000 shares
@ $0.8, valued at
$16k
|
|
| 10/01/2020 |
4
| Marguglio David J. (SVP and Chief Business Officer) has filed a Form 4 on Adamis Pharmaceuticals Corp|
Txns:
| Sold 20,000 shares
@ $0.8, valued at
$16k
|
|
| 08/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|